Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Name Change to Iconic Labs Plc and Results of GM

10 Jul 2019 15:59

RNS Number : 1400F
WideCells Group PLC
10 July 2019
 

10 July 2019

Iconic Labs Plc ("Iconic Labs" or the "Company")

Results of GM - Change of Name to Iconic Labs Plc

 

The Board is pleased to announce that the Company has changed its name to Iconic Labs Plc ('Iconic Labs') to reflect its new focus as a multi-divisional new media and technology business. This change takes effect following the Company's General Meeting ("GM") held today, where all resolutions were duly passed. The new ticker for the Company will be ICON and take effect on 11 July 2019.

 

Iconic Labs provides online marketing, content and technology driven products to enable companies to increase their consumer engagement and build brand presence. The team, led by John Quinlan and Liam Harrington, who were founders and key drivers behind UNILAD, the world's largest social media publisher, is making progress with regards to its new media activities, highlighted by the recently announced consulting and marketing services engagement with a UK-based financial services business, where work has commenced. 

 

The progress made has been achieved with just a soft launch; an official launch is planned, which the Company believes will benefit client acquisitions and brand awareness in the sector. The Board anticipates that the name change will be beneficial to securing new business opportunities, attracting potential complementary acquisitions as well as creating increased visibility for investors. 

 

Iconic Labs operates in a rapidly growing market driven by consumer habits shifting to digital and social from TV and print, increasing numbers of distribution platforms fighting for premium content to attract audiences, and traditional agencies struggling to adapt to client demands and new technologies. As an example, global mobile ad spend is projected to increase from US$138 billion in 2018 to US$212 billion in 2021, while Subscription Video On Demand services rose from 14% of households in 2014 to 39% in 2018. The market is fragmented, and the Board believes that, by utilising its contact base, experience of growing new media businesses and sector knowledge, it can take advantage of this fast-developing market.

 

With regards to the WideCells business, the Board continues to address legacy issues and the cash involved and will inform the market when these have been resolved. It is obviously frustrating for both the management and shareholders that there remain outstanding issues, but the Board is working to alleviate these and ensure that the new business has a firm platform that can be utilised for the benefit of all stakeholders. 

 

The Board looks forward to updating shareholders as it implements its defined growth strategy both organically and via targeted value-accretive acquisitions utilising its platform and paper.

 

Chief Executive Officer, John Quinlan, said: "I'm delighted that the name change to Iconic Labs has been effected as the name reflects the current direction of the business in the new media space. We have a proven track record in the delivery of advice, strategic planning, content provision and developing technology, primarily garnered from our time at UNILAD, which achieved revenues in excess of £10 million per annum; we are utilising this experience to build a business. There is a distinct opportunity in the new media sector and, since joining in March 2019, we have made progress establishing the offering and building out our market presence. The reception from our targeted market has been good and we are now leveraging our team's knowledge, experience and contact base to implement our strategy to create shareholder value."

 

**ENDS**

 

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

 

Shard Capital Partners LLP

Co-broker - Damon Heath, Erik Woolgar

Tel: +44 (0) 20 7186 9950

St Brides Partners Limited

PR - Melissa Hancock, Juliet Earl

Tel: +44 (0) 20 7236 1177

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKMGMNDGMGLZM
Date   Source Headline
5th Mar 201911:00 amRNSPrice Monitoring Extension
28th Feb 20192:20 pmRNSHolding(s) in Company
26th Feb 20195:44 pmRNSHolding(s) in Company
25th Feb 20198:12 amRNSDirectorate Change
22nd Feb 20195:50 pmRNSPublication of Prospectus
20th Feb 20194:06 pmRNSHolding(s) in Company
1st Feb 201912:35 pmRNSHolding(s) in Company
24th Jan 20193:37 pmRNSHolding(s) in Company
15th Jan 201911:14 amRNSHolding(s) in Company
11th Jan 201912:23 pmRNSHolding(s) in Company
10th Jan 201911:19 amRNSHolding(s) in Company
9th Jan 201912:06 pmRNSHolding(s) in Company
15th Nov 20181:03 pmRNSGM Results
14th Nov 20186:07 pmRNSHolding(s) in Company
6th Nov 20182:18 pmRNSIssue and Allotment of Ordinary Shares
31st Oct 20187:00 amRNS3rd Conversion of Bond
30th Oct 20186:10 pmRNSReplacement - Notice of General Meeting
30th Oct 20184:25 pmRNSNotice of AGM
30th Oct 20182:05 pmRNSSecond Price Monitoring Extn
30th Oct 20182:00 pmRNSPrice Monitoring Extension
30th Oct 20187:00 amRNSWideacademy Restructuring
29th Oct 20184:33 pmRNSHolding(s) in Company
23rd Oct 20188:27 amRNSConversion of Bond
22nd Oct 20183:27 pmRNSConversion of bonds
22nd Oct 20187:00 amRNSSmart Cells Deal
19th Oct 20189:20 amRNSHolding(s) in Company
18th Oct 201812:47 pmRNSBoard Restructuring
17th Oct 20184:48 pmRNSHolding(s) in Company
1st Oct 201811:00 amRNSPrice Monitoring Extension
28th Sep 20183:30 pmRNSHolding(s) in Company
27th Sep 20184:40 pmRNSSecond Price Monitoring Extn
27th Sep 20184:35 pmRNSPrice Monitoring Extension
27th Sep 201810:40 amRNSNotification of transactions of Directors
27th Sep 20187:10 amRNSInterim Results
27th Sep 20187:00 amRNSFinancing Agreement
30th Jul 20187:00 amRNSCellPlan Launch in Spain
9th Jul 20187:01 amRNSBoard Changes
9th Jul 20187:00 amRNSHolding(s) in Company
29th Jun 20183:00 pmRNSResult of AGM
28th Jun 201810:30 amRNSResult of General Meeting
15th Jun 20187:00 amRNSAlign Research Initiation of Coverage
12th Jun 20186:25 pmRNSProspectus and Notice of General Meeting
11th Jun 20189:00 amRNSLive Market Bookbuild Closes
11th Jun 20187:30 amRNSRestoration Widecells Group Plc
11th Jun 20187:00 amRNSUpdate Regarding Placing and Financial Position
6th Jun 20183:00 pmRNSNotice of AGM
5th Jun 20187:00 amRNSAudited Preliminary Results
21st May 20187:00 amRNSFinal Results Update
10th May 201810:30 amRNSPlacing to Raise £1.47m and Live Market Bookbuild
3rd May 20187:30 amRNSSuspension Widecells Group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.